What is the ticker symbol for Frequency Therapeutics?

Frequency Therapeutics trades under the ticker FREQ on NASDAQ.

What sector does Frequency Therapeutics operate in?

Frequency Therapeutics is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze FREQ in a portfolio?

PortView shows FREQ's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Frequency Therapeutics (FREQ) Stock Analysis

NASDAQHealthcareBiotechnology

$0.30+4.76%

1-year price historyRange $0.22 – $5.48

52-week range$0.30

$0.18$5.59

What Frequency Therapeutics does

Frequency Therapeutics, Inc. is a clinical-stage biotechnology company dedicated to developing treatments that unlock the body's inherent capacity for regeneration to restore impaired functions. Their "Progenitor Cell Activation" approach leverages small molecules to stimulate progenitor cells within the body, encouraging the formation of new, functional tissues. The company's flagship product candidate, FX-322, is currently in Phase IIa clinical trials, aiming to address the fundamental cause of sensorineural hearing loss. Beyond this, Frequency is also advancing therapies for various degenerative diseases, including multiple sclerosis, and ailments impacting muscles, the gastrointestinal system, skin, and bones. For the development and commercialization of FX-322, the company holds a license and collaboration agreement with Astellas Pharma Inc. Additionally, it maintains collaboration and licensing agreements with esteemed organizations such as Massachusetts Eye and Ear, the Massachusetts Institute of Technology, The Scripps Research Institute, and Cambridge Enterprises Limited. Founded in 2014, Frequency Therapeutics, Inc. is headquartered in Lexington, Massachusetts.

Key metrics

Market cap

$10.94M

P/E (TTM)

-0.16

EPS (TTM)

$-1.90

Beta

0.77

Dividend yield

0.00%

Revenue / share

$0.14

50-day avg

$0.35

200-day avg

$0.64

52-week high

$5.59

52-week low

$0.18

CEO

David L. Lucchino

ETFs linked to FREQ

Broad-market and Healthcare sector ETFs an investor holding Frequency Therapeutics is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how FREQ fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze FREQ in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Frequency Therapeutics?: Frequency Therapeutics trades under the ticker FREQ on NASDAQ.
Which exchange is FREQ listed on?: FREQ is listed on NASDAQ.
What sector does Frequency Therapeutics operate in?: Frequency Therapeutics is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze FREQ in a portfolio?: PortView shows FREQ's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.